基于网络药理学研究三妙散治疗骨关节炎的药理机制

摘要/Abstract

摘要： 目的：基于网络药理学方法研究中医方剂三妙散治疗骨关节炎（osteoarthritis， OA）的药理机制，分析其作用的活性成分、关键靶点和信号通路，以期为三妙散治疗骨关节炎提供理论支持。方法和结果：通过中药系统药理学数据库与分析平台（TCMSP）和DrugBank数据库发现了三妙散的57个潜在活性成分和203个作用靶点，通过GeneCards、TTD、OMIM、DisGeNET和PharmGKB数据库得到1971个骨关节炎相关靶点，利用韦恩分析发现了108个与药物靶点的交集靶点，且交集靶点主要来自化合物槲皮素、山奈酚和汉黄芩素。对交集靶点进行蛋白质相互作用（PPI）分析，将结果导入Cytoscape软件利用CytoNCA插件进行拓扑分析，得到9个三妙散治疗骨关节炎的关键靶点。DAVID富集分析发现，三妙散治疗骨关节炎的主要生物学过程包括氧化应激、对活性氧的反应，凋亡信号通路等；信号通路主要包括PI3K-Akt、IL-17、TNF及细胞凋亡等。结论：三妙散的主要成分槲皮素、山奈酚和汉黄芩素等可能通过ESR1、FOS、JUN、MAPK1、MAPK14、RELA、TP53、TNF和MYC靶点，作用于PI3K-Akt信号通路、IL-17信号通路、TNF信号通路、细胞凋亡信号通路等而发挥治疗骨关节炎的作用。

关键词: font-size:medium, ">三妙散；骨关节炎；网络药理学；药理机制

Abstract: Objective：Based on the therapeutic mechanism of Chinese medicine sanmiaosan (SMS) in the treatment of osteoarthritis (OA)， to analyze the active ingredients and key targets， and investigate the acting pathways using network pharmacology approaches，so as to provide theoretical support for SMS treating OA.Methods and Results：57 active ingredients and 203 targets of SMS were identified by Traditional Chinese Medicine Systems Pharmacology (TCMSP) database and DrugBank database， and 1971 OA related targets were collected by GeneCards， Therapeutic Target Database (TTD)， Online Mendelian Inheritance in Man(OMIM)， DisGeNET， and Pharmaco-genetics Knowledge Base (PharmGKB) databases. After Venn analysis， 108 common targets of SMS and OA were obtained， and they were mainly from quercetin， kaempferol and wogonin. The common targets were analyzed by protein-protein interaction (PPI)， and then the results were imported into Cytoscape software for topological analysis using CytoNCA. Finally， 9 key targets of SMS for the treatment of OA were obtained. According to DAVID enrichment analysis， the main biological processes of SMS in the treatment of OA include oxidative stress， response to reactive oxygen species and apoptotic signaling pathways， and the enriched signaling pathways mainly include PI3K-Akt， IL-17， TNF and apoptosis. Conclusion：The data suggested that the main ingredients of SMS， such as quercetin， kaempferol and wogonin， may play the role in the treatment of OA through the target of ESR1， FOS， JUN， MAPK1， MAPK14， RELA， TP53， TNF and MYC， and act on PI3K-Akt， IL-17， TNF and apoptosis signaling pathways.

Key words: Sanmiaosan, Osteoarthritis, Network pharmacology, Therapeutic mechanisms

中图分类号:

楚曼, 张续, 贺弯弯, 康武林, 赵莉平, 蔡哲, 袁普卫. 基于网络药理学研究三妙散治疗骨关节炎的药理机制[J]. 中国医药导刊, 2022, 24(12): 1230-1237.

CHU Man, ZHANG Xu, HE Wanwan, KANG Wulin, ZHAO Liping, CAI Zhe, YUAN Puwei. Elucidation of Mechanisms of Sanmiaosan in the Treatment of Osteoarthritis Based on Network Pharmacology#br# [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2022, 24(12): 1230-1237.

参考文献

[1]Van Spil WE， Kubassova O， Boesen M， et al. Osteoarthritis phenotypes and novel therapeutic targets[J]. Biochem Pharmacol， 2019， 165：41-48.
     [2]Mandl LA. Osteoarthritis year in review 2018： clinical[J]. Osteoarthritis Cartilage， 2019， 27(3)： 359-364.
     [3]Hawker GA， Gignac MA， Badley E， et al. A longitudinal study to explain the pain-depression link in older adults with osteoarthritis[J]. Arthritis Care Res (Hoboken)， 2011， 63(10)： 1382-1390.
     [4]Wong LY， Yiu RL， Chiu CK， et al. Prevalence of psychiatric morbidity in Chinese subjects with knee osteoarthritis in a Hong Kong orthopaedic clinic[J]. East Asian Arch Psychiatry， 2015， 25(4)： 150-158.
     [5]Branco JC， Rodrigues AM， Gouveia N， et al. Prevalence of rheumatic and musculoskeletal diseases and their impact on health-related quality of life， physical function and mental health in Portugal： results from EpiReumaPt-a national health survey[J]. RMD Open， 2016， 2(1)： e000166.
     [6]Rafanan BS， Valdecanas BF， Lim BP， et al. Consensus recommendations for managing osteoarthritic pain with topical NSAIDs in Asia-Pacific[J]. Pain Manag， 2018， 8(2)：115-128.
     [7]Smith SR， Deshpande BR， Collins JE， et al. Comparative pain reduction of oral non-steroidal anti-inflammatory drugs and opioids for knee osteoarthritis： systematic analytic review[J]. Osteoarthritis Cartilage， 2016， 24(6)：962-972.
     [8]Watt FE， Gulati M. New drug treatments for osteoarthritis： what is on the horizon?[J].Eur Med J Rheumatol， 2017， 2(1)：50-58.
     [9]邓中甲. 方剂学 [M]. 人民卫生出版社. 2012.
     [10]胡军平，李芳霞，吕伟，等.三妙散方加味治疗急性痛风性关节炎的疗效观察[J].内蒙古医学杂志，2018，50(8)：933-934.
     [11]杨晶，袁慧慧，艾娟娟，等. 三妙散合舒筋散治疗早期湿热阻络证类风湿性关节炎的疗效观察[J]. 湖南中医药大学学报， 2017， 37(7)： 774-777.
     [12]Deligne C， Casulli S， Pigenet A， et al. Differential expression of interleukin-17 and interleukin-22 in inflamed and non-inflamed synovium from osteoarthritis patients[J]. Osteoarthritis Cartilage， 2015， 23(11)： 1843-1852.
     [13]史红丽，王玲秀，应亚美，等. 加味三妙散治疗湿热下注型早期膝骨关节炎37例体会[J]. 中国民族民间医药， 2014，(21)：85.
     [14]Chu M， Wu P， Hong M et al. Lingzhi and San-Miao-San with hyaluronic acid gel mitigate cartilage degeneration in anterior cruciate ligament transection induced osteoarthritis[J]. J Orthop Translat， 2021， 26(1)：132-140.
     [15]Ru J， Li P， Wang J， et al. TCMSP： a database of systems pharmacology for drug discovery from herbal medicines[J]. J Cheminform， 2014， 6(1)： 13-18.
     [16]Wishart DS， Craig K， Guo AC， et al. Drugbank： a knowledgebase for drugs， drug actions and drug targets[J]. Nucleic Acids Res， 2007， 36(suppl_1)： D901-D906.
     [17]Marilyn S， Irina D， Justin A， et al. GeneCards Version 3： the human gene integrator[J]. Database， 2010， doi： 10.1093/database/baq020.
     [18]Ada H， Scott AF， Joanna A， et al. Online mendelian inheritance in man (omim)， a knowledgebase of human genes and genetic disorders[J]. Nucleic Acids Res， 2005， 33(1)： 514-517.
     [19]Janet P， Alex B， Núria Q-R， et al. DisGeNET： a comprehensive platform integrating information on human disease-associated genes and variants[J]. Nuclc Acids Res， 2017， 45(D1)：D833-D839.
     [20]Wang Y， Zhang S， Li F， et al. Therapeutic target database 2020： enriched resource for facilitating research and early development of targeted therapeutics[J]. Nucleic Acids Res， 2020， 48(D1)： 1031-1041.
     [21]Micheal H， Diane EO， Daniel LR， et al. PharmGKB： the pharmacogenetics knowledge base[J]. Nuclc Acids Research， 2002， 30(1)： 163-165.
     [22]Lopes CT， Franz M， Kazi F， et al. Cytoscape web： an interactive web-based network browser[J]. Bioinformatics， 2010， 26(18)： 2347-2348.
     [23]Mering C， Huynen M， Jaeggi D， et al. STRING： a database of predicted functional associations between proteins[J]. Nucleic Acids Res， 2003， 31(1)： 258-261.
     [24]Huang DW， Sherman BT， Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources[J]. Nat Protoc， 2009， 4(1)： 44-57.
     [25]Shen M， Tian S， Li Y， et al. Drug-likeness analysis of traditional Chinese medicines： 1. Property distributions of drug-like compounds， non-drug-like compounds and natural compounds from traditional chinese medicines[J]. J Cheminform， 2012， 4(1)： 31-36.
     [26]张俐. 中医骨病学 [M]. 上海科学技术出版社， 2012.
     [27]Zhang J， Yin J， Zhao D， et al. Therapeutic effect and mechanism of action of quercetin in a rat model of osteoarthritis[J]. J Int Med Res， 2019， 48(3)：0300060519873461.
     [28]Hu Y， Gui Z， Zhou Y， et al. Quercetin alleviates rat osteoarthritis by inhibiting inflammation and apoptosis of chondrocytes， modulating synovial macrophages polarization to M2 macrophages[J]. Free Radic Biol Med， 2019， 145：146-160.
     [29]Feng K， Chen Z， Pengcheng L， et al. Quercetin attenuates oxidative stress-induced apoptosis via SIRT1/AMPK-mediated inhibition of ER stress in rat chondrocytes and prevents the progression of osteoarthritis in a rat model[J]. J Cell Physiol， 2019， 234(10)： 18192-18205.
     [30]Kim SH， Park JG， Sung GH， et al. Kaempferol， a dietary flavonoid， ameliorates acute inflammatory and nociceptive symptoms in gastritis， pancreatitis， and abdominal pain[J].Mol Nutr Food Res， 2015， 59(7)： 1400-1405.
     [31]Zhuang Z， Ye G， Huang B. Kaempferol alleviates the interleukin-1β-induced inflammation in rat osteoarthritis chondrocytes via suppression of NF-κB[J]. Med Sci Monit， 2017， 23：3925-3931.
     [32]Jiang R， Hao P， Yu G， et al. Kaempferol protects chondrogenic ATDC5 cells against inflammatory injury triggered by lipopolysaccharide through down-regulating miR-146a[J]. Int Immunopharmacol， 2019， 69：373-381.
     [33]Khan NM， Haseeb A， Ansari MY， et al. Wogonin， a plant derived small molecule， exerts potent anti-inflammatory and chondroprotective effects through the activation of ROS/ERK/Nrf2 signaling pathways in human osteoarthritis chondrocytes[J]. Free Radic Biol Med， 2017， 106：288-293.
     [34]Lijnen HR. Matrix metalloproteinases and cellular fibrinolytic activity[J]. Biochemistry (Mosc)， 2002， 67(1)： 92-98.
     [35]Park JS， Lee HJ， Lee DY， et al. Chondroprotective effects of wogonin in experimental models of osteoarthritis in vitro and in vivo[J]. Biomol Ther (Seoul)， 2015， 23(5)： 442-448.
     [36]Zhou X， Jiang L， Fan G， et al. Role of the ciRS-7/miR-7 axis in the regulation of proliferation， apoptosis and inflammation of chondrocytes induced by IL-1β[J]. Int Immunopharmacol， 2019， 71：233-240.
     [37]Yang H， Wu D， Li H， et al. Downregulation of microRNA-448 inhibits IL-1β-induced cartilage degradation in human chondrocytes via upregulation of matrilin-3[J]. Cell Mol Biol Lett， 2018， 23：7-14.
     [38]Lepetsos P， Papavassiliou AG. ROS/oxidative stress signaling in osteoarthritis[J]. Biochim Biophys Acta， 2016， 1862(4)： 576-591.
     [39]Jolback P， Rolfson O， Mohaddes M， et al. Does surgeon experience affect patient-reported outcomes 1 year after primary total hip arthroplasty?[J]. Acta Orthop， 2018， 89(3)： 265-271.
     [40]Henrotin YE， Bruckner P， Pujol JP. The role of reactive oxygen species in homeostasis and degradation of cartilage[J]. Osteoarthritis Cartilage， 2003， 11(10)： 747-755.
     [41]Li D， Wang W， Xie G. Reactive oxygen species： the 2-edged sword of osteoarthritis[J]. Am J Med Sci， 2012， 344(6)： 486-491.
     [42]Ulici V， Hoenselaar KD， Gillespie JR， et al. The PI3K pathway regulates endochondral bone growth through control of hypertrophic chondrocyte differentiation[J]. BMC Dev Biol， 2008， 8：40-45.
     [43]Yue L， Haroun S， Parent JL， et al. Prostaglandin D(2) induces apoptosis of human osteoclasts through ERK1/2 and Akt signaling pathways[J]. Bone， 2014， 60：112-121.
     [44]罗心静，莫选荣，周玲玲. TNF-α诱导类风湿关节炎滑膜细胞NF-κB信号通路活化的探讨[J]. 免疫学杂志， 2012， 28(4)： 321-323.
     [45]Pisani P， Estadella D， Ribeiro DA. The role of toll like receptors (TLRs) in oral carcinogenesis[J]. Anticancer Res， 2017， 37(10)： 5389-5394.
     [46]Zhang J， Yin J， Zhao D， et al. Therapeutic effect and mechanism of action of quercetin in a rat model of osteoarthritis[J]. J Int Med Res， 2020， 48(3)： 300060519873461

快速检索引用检索图表检索高级检索